roche holding ag-genusschein
(ROG:SIX SWISS EXCHANGE AG)
Richard H. Scheller Ph.D.
Former Head of Genentech Research & Early Development, Roche Holding AG
|Age||Total Calculated Compensation||This person is connected to 24 board members in 3 different organizations across 8 different industries.|
See Board Relationships
Dr. Richard H. Scheller, Ph.D., has been the Chief Science Officer and Head of Therapeutics at 23andMe, Inc. since March 12, 2015. Dr. Scheller served as an Executive Vice President of Research & Early Development for Genentech, Inc. since September 2003. He was responsible for setting the strategy for Genentech's research and drug discovery activities. He served as the Head of Genentech Research & Early Development at Roche Holding AG from 2009 to December 31, 2014. ...
Konzern-HauptsitzPhone: 41 61 688 11 11
Basel, Basel-Stadt 4070
Fax: 41 61 691 93 91
Board Members Memberships*
University of Wisconsin - Madison
California Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|